Glywohn VM 1mg/500mg/0.2mg Tablet
Marketer
Riyadh Pharmaceutical
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Glywohn VM 1mg/500mg/0.2mg Tablet
Diabetic medication, Combiflor 1mg/500mg/0.2mg tablets, is a triple-combination therapy for adult type 2 diabetes. This medication helps regulate blood glucose. Always take Combiflor with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical supervision risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are integral to diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect; learn to identify symptoms like sweating, dizziness, headache, and tremors, and carry readily available glucose sources (e.g., sugary snacks, juice). Alcohol increases hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, swelling, blurred vision, fractures, and upper respiratory infections. Weight gain is also possible. Do not use Combiflor if you have type 1 diabetes, diabetic ketoacidosis, or severe liver or kidney disease. Inform your doctor of any history of heart conditions before commencing treatment; pregnancy or breastfeeding necessitates prior physician consultation. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are recommended.
Uses of Glywohn VM 1mg/500mg/0.2mg Tablet
Managing type 2 diabetes
Major Benefits of Glywohn VM 1mg/500mg/0.2mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glywohn VM 1mg/500mg/0.2mg Tablets should be taken on an empty stomach.
Common Side effects of Glywohn VM 1mg/500mg/0.2mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glywohn VM 1mg/500mg/0.2mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the Glywohn VM 1mg/500mg/0.2mg Tablet whole; avoid chewing, crushing, or fracturing it. Consumption should occur on an empty stomach.
How Glywohn VM 1mg/500mg/0.2mg Tablet works:
Each Glywohn VM tablet (1mg/500mg/0.2mg) contains a triple-action blend of antidiabetic medications.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Glywohn VM 1mg/500mg/0.2mg tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glywohn VM 1mg/500mg/0.2mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against possible risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
The use of Glywohn VM 1mg/500mg/0.2mg tablets while breastfeeding is likely inadvisable. Preliminary human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Employing Glywohn VM 1mg/500mg/0.2mg tablets in individuals with kidney impairment carries a significant risk and should be strictly avoided. Medical advice is essential. Furthermore, the use of Glywohn VM 1mg/500mg/0.2mg tablets is contraindicated for patients exhibiting severe kidney dysfunction.
LiverCAUTION
Individuals with liver impairment should use Glywohn VM 1mg/500mg/0.2mg tablets cautiously, potentially requiring dosage modifications. Consultation with a physician is advised. For those with mild to moderate liver disease, initiation with a low dose is typical; however, its use is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Glywohn VM 1mg/500mg/0.2mg Tablet :
Should you forget a Glywohn VM 1mg/500mg/0.2mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glywohn VM 1mg/500mg/0.2mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently